Baseline gut microbiota and metabolome predict durable immunogenicity to SARS-CoV-2 vaccines.

MLA

Peng, Ye, et al. “Baseline Gut Microbiota and Metabolome Predict Durable Immunogenicity to SARS-CoV-2 Vaccines.” Signal Transduction and Targeted Therapy, vol. 8, no. 1, Sept. 2023, p. 373. EBSCOhost, https://doi.org/10.1038/s41392-023-01629-8.

APA

Peng, Y., Zhang, L., Mok, C. K. P., Ching, J. Y. L., Zhao, S., Wong, M. K. L., Zhu, J., Chen, C., Wang, S., Yan, S., Qin, B., Liu, Y., Zhang, X., Cheung, C. P., Cheong, P. K., Ip, K. L., Fung, A. C. H., Wong, K. K. Y., Hui, D. S. C., … Tun, H. M. (2023). Baseline gut microbiota and metabolome predict durable immunogenicity to SARS-CoV-2 vaccines. Signal Transduction and Targeted Therapy, 8(1), 373. https://doi.org/10.1038/s41392-023-01629-8

Chicago

Peng, Ye, Lin Zhang, Chris K P Mok, Jessica Y L Ching, Shilin Zhao, Matthew K L Wong, Jie Zhu, et al. 2023. “Baseline Gut Microbiota and Metabolome Predict Durable Immunogenicity to SARS-CoV-2 Vaccines.” Signal Transduction and Targeted Therapy 8 (1): 373. doi:10.1038/s41392-023-01629-8.